Cardiovascular Systems Investor Relations Material
Latest events
Q1 2023
Cardiovascular Systems
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cardiovascular Systems Inc
Access all reports
Cardiovascular Systems Inc. develops and commercializes medical devices used to treat peripheral and coronary artery disease. The company’s product portfolio focuses on minimally invasive procedures designed to modify arterial plaque and restore blood flow in patients with arterial blockages. It serves hospitals, physicians, and outpatient centers. The company is headquartered in St. Paul, Minnesota, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CSII
Country
🇺🇸 United States